California State Teachers Retirement System Sells 65,394 Shares of Kenvue Inc. $KVUE

California State Teachers Retirement System lessened its position in shares of Kenvue Inc. (NYSE:KVUE) by 2.0% in the first quarter, HoldingsChannel.com reports. The firm owned 3,144,036 shares of the company’s stock after selling 65,394 shares during the quarter. California State Teachers Retirement System’s holdings in Kenvue were worth $54,203,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Readystate Asset Management LP raised its holdings in Kenvue by 76.8% during the 1st quarter. Readystate Asset Management LP now owns 1,057,316 shares of the company’s stock worth $18,228,000 after purchasing an additional 459,192 shares during the last quarter. Royal Bank of Canada boosted its stake in shares of Kenvue by 78.6% in the 1st quarter. Royal Bank of Canada now owns 8,979,296 shares of the company’s stock valued at $154,802,000 after purchasing an additional 3,952,444 shares during the last quarter. Empowered Funds LLC boosted its stake in shares of Kenvue by 7.9% in the 1st quarter. Empowered Funds LLC now owns 171,972 shares of the company’s stock valued at $2,965,000 after purchasing an additional 12,527 shares during the last quarter. Maverick Capital Ltd. acquired a new stake in shares of Kenvue during the first quarter worth $1,586,000. Finally, Quantinno Capital Management LP increased its position in shares of Kenvue by 59.5% during the first quarter. Quantinno Capital Management LP now owns 1,345,956 shares of the company’s stock worth $23,204,000 after buying an additional 502,024 shares during the period. Institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.59% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. Citigroup dropped their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Barclays increased their price target on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Zacks Research lowered Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. UBS Group boosted their price objective on Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research note on Thursday, July 16th. Finally, Weiss Ratings upgraded Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. Three research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $19.58.

Kenvue Stock Performance

NYSE:KVUE opened at $19.27 on Friday. The company has a fifty day moving average of $18.56 and a 200-day moving average of $18.00. The firm has a market capitalization of $37.00 billion, a P/E ratio of 22.67, a P/E/G ratio of 1.50 and a beta of 0.47. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $22.28.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.05. The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. Kenvue’s revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.24 earnings per share. As a group, sell-side analysts anticipate that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 12th will be issued a dividend of $0.21 per share. This is an increase from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.84 annualized dividend and a dividend yield of 4.4%. The ex-dividend date is Wednesday, August 12th. Kenvue’s dividend payout ratio (DPR) is currently 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.